US Map / Kentucky
State KY

Clinical Trials in Kentucky

Kentucky is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kentucky and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 140 actively recruiting studies with Kentucky sites out of 140 registered in total. The busiest research areas in Kentucky are Non-Small Cell Lung Cancer, Colorectal Cancer, Ulcerative Colitis. Leading sponsors running trials in the state include University of Louisville, National Cancer Institute (NCI), Merck Sharp & Dohme LLC. By stage, Kentucky trials break down as Phase 1 (20), Phase 2 (36), Phase 3 (42), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
140
Recruiting Now
140
← Back to US Map
Top Conditions in Kentucky
Non-Small Cell Lung Cancer (3)Colorectal Cancer (3)Ulcerative Colitis (3)Hidradenitis Suppurativa (HS) (2)Multiple Myeloma (2)Asthma (2)Head and Neck Cancer (2)Esophageal Cancer (2)Large B-cell Lymphoma (2)Cancer (2)NSCLC (2)Stroke (2)

Frequently Asked Questions — Clinical Trials in Kentucky

How many clinical trials are currently recruiting in Kentucky?
ClinicalMetric currently tracks 140 actively recruiting clinical trials with at least one location in Kentucky. The total number of registered studies—including active but not currently enrolling trials—is 140. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kentucky?
Kentucky hosts clinical trials across a broad range of medical conditions, including Non-Small Cell Lung Cancer, Colorectal Cancer, Ulcerative Colitis, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kentucky serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kentucky?
To join a clinical trial in Kentucky, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kentucky maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Kentucky

NCT04614103 Phase 2
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Condition
Metastatic Non Small Cell Lung Cancer
Enrollment
170 pts
Location
United States, Australia, Canada
Sponsor
Iovance Biotherapeutics, Inc.
View Trial →
NCT06644261 Phase 4
Recruiting
Transvaginal Versus Fluoroscopy-guided Trans Gluteal Pudendal Nerve Block for Pu...
Condition
Pudendal Neuralgia
Enrollment
40 pts
Location
United States
Sponsor
University of Louisville
View Trial →
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
View Trial →
NCT07082738 Phase 2
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Ve...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
987 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05729932 Phase 1
Recruiting
Cannabis and Opioid Use Disorder
Condition
Opioid Use Disorder
Enrollment
15 pts
Location
United States
Sponsor
Shanna Babalonis, PhD
View Trial →
NCT06252649 Phase 3
Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevac...
Condition
Metastatic Colorectal Cancer
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT05911568 N/A
Recruiting
Treatment With Endovascular Intervention for STroke Patients With Existing Disab...
Condition
Stroke
Enrollment
1,060 pts
Location
United States
Sponsor
University of Cincinnati
View Trial →
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
View Trial →
NCT07086794 EARLY_Phase 1
Recruiting
Cocaine and Pentoxifylline (BED IN 47)
Condition
Cocaine Use Disorder
Enrollment
30 pts
Location
United States
Sponsor
William Stoops
View Trial →
NCT03153683 N/A
Recruiting
Brain, Blood And Clot or Tissue Registry And Collaboration
Condition
Acute Ischemic Stroke
Enrollment
1,000 pts
Location
United States
Sponsor
Justin Fraser
View Trial →
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT07277946 N/A
Recruiting
AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Saf...
Condition
Hernia
Enrollment
240 pts
Location
United States
Sponsor
Tissium
View Trial →
NCT05142189 Phase 1
Recruiting
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of B...
Condition
Non-Small Cell Lung Cancer
Enrollment
320 pts
Location
United States, Australia, Germany
Sponsor
BioNTech SE
View Trial →
NCT04781140 Phase 4
Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Chi...
Condition
Attention-Deficit/Hyperactivity Disorder
Enrollment
286 pts
Location
United States
Sponsor
Supernus Pharmaceuticals, Inc.
View Trial →
NCT05446259 N/A
Recruiting
Degenerative Cervical Myelopathy Repository
Condition
Cervical Myelopathy
Enrollment
245 pts
Location
United States
Sponsor
Francis Farhadi
View Trial →
NCT03670524 N/A
Recruiting
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Proje...
Condition
Cardiovascular Diseases
Enrollment
835 pts
Location
United States
Sponsor
University of Louisville
View Trial →
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT06843317 Phase 1
Recruiting
Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adult...
Condition
RSV Infection
Enrollment
160 pts
Location
United States
Sponsor
Clover Biopharmaceuticals USA,
View Trial →
NCT07417943 N/A
Recruiting
Neuromodulation to Enhance Motor Function in HSP
Condition
Hereditary Spastic Paraplegia
Enrollment
15 pts
Location
United States
Sponsor
Rahul Sachdeva
View Trial →
NCT06967389 N/A
Recruiting
Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
Condition
Obesity and Overweight
Enrollment
50 pts
Location
United States
Sponsor
John Bauer
View Trial →
NCT07450547 Phase 2
Recruiting
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Condition
Exocrine Pancreatic Insufficiency (EPI)
Enrollment
113 pts
Location
United States
Sponsor
Anagram Therapeutics, Inc.
View Trial →
NCT06249126 N/A
Recruiting
Primary Subtalar Arthrodesis for Calcaneal Fractures
Condition
Calcaneus Fracture
Enrollment
218 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT04427384 N/A
Recruiting
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Condition
Brain Tumor, Recurrent
Enrollment
600 pts
Location
United States
Sponsor
GT Medical Technologies, Inc.
View Trial →
NCT07037459 Phase 3
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejecti...
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
5,056 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT07355062 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Me...
Condition
CKD
Enrollment
150 pts
Location
United States
Sponsor
Renibus Therapeutics, Inc.
View Trial →
Page 3 of 6 — 140 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology